U.S. EPA Approves Ocean Bio-Chem's New Liquid Disinfectant, Xtrem-A-Cide P(R) -- Effective Against Salmonella, Hepatitis A,

U.S. EPA Approves Ocean Bio-Chem's New Liquid Disinfectant, Xtrem-A-Cide P(R) --
 Effective Against Salmonella, Hepatitis A,
Influenza-A, E-Coli, Numerous Other Viruses and Fungi 
FORT LAUDERDALE, FL -- (Marketwire) -- 02/25/13 --  Ocean Bio-Chem,
Inc. (NASDAQ: OBCI), a leading manufacturer and distributor of
appearance, performance, and maintenance products serving the marine,
automotive, power sports, recreational vehicle and outdoor power
equipment markets, is pleased to announce the U.S. Environmental
Protection Agency approval of Ocean Bio-Chem's new product,
Xtrem-A-Cide P(R), a broad-spectrum disinfectant that is approved for
use as a sanitizer, virucide, tuberculocide, fungicide, algaecide,
slimicide and deodorizer.  
This new product is an extension of Star brite's OdorStar line of
NosGuard(R) mold and mildew products. 
"Xtrem-A-Cide P(R) utilizes Ocean Bio-Chem's patented technology to
generate a chlorine dioxide solution which can be applied as a
deep-penetrating spray for easy application," said Peter Dornau, CEO. 
Chlorine dioxide is a proven disinfectant and deodorizing agent. It
is widely used in municipal water treatment operations, in
toothpaste, mouthwashes, and to eliminate bedbugs in hotels. Chlorine
dioxide was also the agent used to remediate buildings contaminated
in 2001 by Anthrax bacteria and more recently was used to eliminate
mold from homes and buildings in New Orleans and the surrounding area
that were flooded during Hurricane Katrina. 
"The applications and markets for this new product are immense,
ranging from home use to hospitals, cruise ships, hotels and other
hospitality facilities, gyms, rest rooms, arenas, food processing
operations, schools and other facilities," Mr. Dornau explained. 
When used as directed, Xtrem-A-Cide P(R) has been approved for
surface eradication of Staphylococcus aureus (MRSA), salmonella,
HIV1, Hepatitis A, Herpes Simplex-2, Influenza-A, Rhinovirus Type 37,
E-Coli and many more viruses and fungi. While extremely powerful, the
new product is designed to be easily applied with a minimum of
Xtrem-A-Cide P(R) will be manufactured in Star brite's 300,000 square
foot manufacturing and distribution facility in Montgomery, Alabama,
in a recently constructed state-of-the-art "clean room" where the
Company is currently manufacturing other chlorine dioxide products
designed for marine, RV and automotive use. 
"We are enthusiastic about the potential future revenues and profits
this product can generate. The addition of Xtrem-A-Cide P(R) will
position Ocean Bio-Chem to continue its rapid expansion into many
additional new markets," Mr. Dornau concluded.  
About Ocean Bio-Chem, Inc.:
 Ocean Bio-Chem, Inc. is principally
engaged in the manufacturing, marketing and distribution of a broad
line of appearance and maintenance products for boats, recreational
vehicles, automobiles, power sports, outdoor power equipment and
motorcycle markets under the Star brite(R) StarTron(R) and other
trademarks within the United States of America and Canada. In
addition, the Company produces private label formulations of many of
its products for various customers and provides custom blending and
packaging services for these and other products.  
The Company trades publicly under NASDAQ Capital Markets, Ticker
Symbol: OBCI.  
The Company's web sites are: www.oceanbiochem.com, www.starbrite.com
and www.startron.com and nos-guard.com  
Forward-looking Statements: 
 Certain statements contained in this
Press Release including without limitation expectations as to future
sales and operating results, constitute forward-looking statements.
For this purpose, any statements contained in this report that are
not statements of historical fact may be deemed forward-looking
statements. Without limiting the generality of the foregoing, words
such as "believe," "may," "will," "expect," "anticipate," "intend,"
"could" including the negative or other variations thereof or
comparable terminology are intended to identify forward-looking
statements. These statements involve known and unknown risks,
uncertainties and other factors which may cause our actual results,
performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by
such forward-looking statements. Factors that may affect these
results include, but are not limited to, the highly competitive
nature of our industry, reliance on certain key customers, changes in
consumer demand for marine, recreational vehicle and automotive
products, advertising and promotional efforts, exposure to market
risks for changes in interest rates and in foreign exchange rates,
and other factors.  
Peter Dornau 
CEO and President 
Jeff Barocas
Vice President & CFO
Paul Knopick
E & E Communications
Press spacebar to pause and continue. Press esc to stop.